Publication | Closed Access
Comparable efficacy and safety of brodalumab in obese and nonobese patients with psoriasis: analysis of two randomized controlled trials
29
Citations
8
References
2019
Year
The efficacy and safety of brodalumab did not differ between patients with moderate-to-severe psoriasis who had a BMI < 30 kg m<sup>-2</sup> or a BMI ≥ 30 kg m<sup>-2</sup> .
| Year | Citations | |
|---|---|---|
Page 1
Page 1